Related Experiment Video
Updated: Jun 21, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Molecular therapies for heritable blistering diseases
Katsuto Tamai1, Yasufumi Kaneda, Jouni Uitto
1Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita City, Osaka, 565-0871, Japan.
Trends in Molecular Medicine
|July 8, 2009
Summary
Molecular genetics has advanced understanding of heritable skin diseases like epidermolysis bullosa (EB). Current research focuses on molecular therapies, including gene therapy, for treating EB and similar intractable skin conditions.
Area of Science:
- Dermatology
- Molecular Genetics
- Genetic Medicine
Background:
- Heritable skin diseases, exemplified by epidermolysis bullosa (EB), are debilitating genetic disorders.
- EB is caused by mutations in genes of the cutaneous basement membrane zone, leading to severe blistering.
- Despite diagnostic and prognostic advancements, effective treatments for EB remain elusive.
Purpose of the Study:
- To review recent progress in molecular genetics of heritable skin diseases.
- To explore novel molecular therapies for epidermolysis bullosa and other intractable genetic skin conditions.
Main Methods:
- Review of recent scientific literature on molecular genetics and therapies for heritable skin diseases.
- Focus on advancements in gene therapy, protein replacement therapy, and stem cell transfer.
Main Results:
- Identification of specific gene mutations has refined EB diagnosis and prognosis.
- Molecular approaches offer potential therapeutic strategies for EB.
Conclusions:
- Significant progress in molecular genetics has improved understanding and diagnosis of EB.
- Emerging molecular therapies hold promise for treating EB and other intractable heritable skin diseases.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...